Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Selective adenosine A1 agonists for cardiovascular ischemic disorders claimed by GSK

Aug. 2, 2002

Inhibitors of protein kinase C and/or glycogen synthase kinase-3 in Ortho-McNeil patent

Aug. 2, 2002

Genzyme Biosurgery and Myosix to advance autologous cell therapy for heart disease

Aug. 2, 2002

Therapeutic angiogenic effects of rFGF-2 in patients with intermittent claudication

Aug. 1, 2002

Safe transition from i.v. epoprostenol to s.c. treprostinil in patients with PAH

Aug. 1, 2002

Manufacturing approval obtained for Onoact

July 31, 2002

Safety and efficacy demonstrated for phVEGF2 in dose-escalating phase I/II trial

July 31, 2002

Third-generation beta1/alpha-adrenoceptor blocker with hypotensive and bradycardic effects

July 31, 2002

Enrollment complete in tecadenoson phase III trial

July 31, 2002

Novel Na+/HCO3- cotransporter inhibitors described in recent patent

July 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...